首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21144篇
  免费   1693篇
  国内免费   34篇
耳鼻咽喉   169篇
儿科学   787篇
妇产科学   557篇
基础医学   2889篇
口腔科学   268篇
临床医学   3157篇
内科学   3519篇
皮肤病学   194篇
神经病学   1903篇
特种医学   518篇
外国民族医学   1篇
外科学   2224篇
综合类   653篇
一般理论   39篇
预防医学   2985篇
眼科学   421篇
药学   1169篇
中国医学   11篇
肿瘤学   1407篇
  2023年   92篇
  2022年   115篇
  2021年   372篇
  2020年   242篇
  2019年   369篇
  2018年   389篇
  2017年   285篇
  2016年   360篇
  2015年   450篇
  2014年   567篇
  2013年   937篇
  2012年   1338篇
  2011年   1385篇
  2010年   684篇
  2009年   652篇
  2008年   1222篇
  2007年   1349篇
  2006年   1340篇
  2005年   1328篇
  2004年   1312篇
  2003年   1247篇
  2002年   1212篇
  2001年   305篇
  2000年   254篇
  1999年   279篇
  1998年   268篇
  1997年   240篇
  1996年   230篇
  1995年   217篇
  1994年   186篇
  1993年   165篇
  1992年   201篇
  1991年   209篇
  1990年   233篇
  1989年   199篇
  1988年   199篇
  1987年   167篇
  1986年   155篇
  1985年   153篇
  1984年   148篇
  1983年   151篇
  1982年   127篇
  1981年   140篇
  1980年   112篇
  1979年   126篇
  1978年   93篇
  1977年   86篇
  1976年   94篇
  1975年   75篇
  1974年   95篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
ABSTRACT

Measuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised.  相似文献   
3.
ABSTRACT

This work collates data from the analysis of complex mixtures analysed in STRmix during routine no-suspect volume crime work. It interrogates the upload rate for these types of mixtures and which component of the profile has been able to be interpreted for upload. The number of profiles giving multiple uploads and the amount of replicate PCR analysis has been collated.  相似文献   
4.
5.
6.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
7.
8.
9.
10.
Over 100 mutations in the presenilin‐1 gene (PSEN1) have been shown to result in familial early onset Alzheimer disease (EOAD), but only a relatively few give rise to plaques with an appearance like cotton wool (CWP) and/or spastic paraparesis (SP). A family with EOAD, seizures and CWP was investigated by neuropathological study and DNA sequencing of the PSEN1 gene. Aβ was identified in leptomeningeal vessels and in cerebral plaques. A single point mutation, p.L420R (g.1508T > G) that gives rise to a missense mutation in the eighth transmembrane (TM8) domain of PS1 was identified in two affected members of the family. p.L420R (g.1508T > G) is the mutation responsible for EOAD, seizures and CWP without SP in this family.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号